Lv21
140 积分 2021-11-02 加入
Chronic Spontaneous Urticaria: Current and Emerging Biologic Agents
2小时前
待确认
Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development
2小时前
已完结
Depletion of mast cells with barzolvolimab, an anti-KIT antibody, does not affect mast cell progenitors
2小时前
已完结
Patent Landscape of Platelet Growth Factor Receptor and c-KIT Targets
4小时前
已完结
Patent landscape of platelet growth factor receptor and c-KIT targets
4小时前
已关闭
Past and present discovery of the BAFF/APRIL system - A bibliometric study from 1999 to 2023
1个月前
已完结
Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency
1个月前
已关闭
Telitacicept: First Approval
1个月前
已完结
Panitumumab the first fully human monoclonal antibody: from the bench to the clinic
3个月前
已完结
Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer
3个月前
已完结
皖公网安备34019202002308
